231 related articles for article (PubMed ID: 28688464)
1. Parkinson Disease and Melanoma: Confirming and Reexamining an Association.
Dalvin LA; Damento GM; Yawn BP; Abbott BA; Hodge DO; Pulido JS
Mayo Clin Proc; 2017 Jul; 92(7):1070-1079. PubMed ID: 28688464
[TBL] [Abstract][Full Text] [Related]
2. Increasing Incidence and Decreasing Mortality of Cutaneous Melanoma in Middle-Aged Adults: An Epidemiologic Study in Olmsted County, Minnesota.
Campbell EH; Reinhart JP; Crum OM; Proffer SL; Weaver A; Gibson LE; Brewer JD; Demer AM
Mayo Clin Proc; 2023 May; 98(5):713-722. PubMed ID: 37137643
[TBL] [Abstract][Full Text] [Related]
3. Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota.
Reed KB; Brewer JD; Lohse CM; Bringe KE; Pruitt CN; Gibson LE
Mayo Clin Proc; 2012 Apr; 87(4):328-34. PubMed ID: 22469345
[TBL] [Abstract][Full Text] [Related]
4. Increasing incidence of melanoma among middle-aged adults: an epidemiologic study in Olmsted County, Minnesota.
Lowe GC; Saavedra A; Reed KB; Velazquez AI; Dronca RS; Markovic SN; Lohse CM; Brewer JD
Mayo Clin Proc; 2014 Jan; 89(1):52-9. PubMed ID: 24388022
[TBL] [Abstract][Full Text] [Related]
5. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.
Bertoni JM; Arlette JP; Fernandez HH; Fitzer-Attas C; Frei K; Hassan MN; Isaacson SH; Lew MF; Molho E; Ondo WG; Phillips TJ; Singer C; Sutton JP; Wolf JE;
Arch Neurol; 2010 Mar; 67(3):347-52. PubMed ID: 20212233
[TBL] [Abstract][Full Text] [Related]
6. Increasing Incidence and Decreasing Mortality of Melanoma in Elderly Adults: An Epidemiologic Study in Olmsted County, Minnesota.
Proffer SL; Reinhart JP; Campbell EH; Crum OM; Gibson LE; Brewer JD; Demer AM
Dermatol Surg; 2024 Feb; 50(2):125-130. PubMed ID: 37792642
[TBL] [Abstract][Full Text] [Related]
7. Population-based incidence of conjunctival tumours in Olmsted County, Minnesota.
Dalvin LA; Salomão DR; Patel SV
Br J Ophthalmol; 2018 Dec; 102(12):1728-1734. PubMed ID: 29511061
[TBL] [Abstract][Full Text] [Related]
8. TNF-Alpha Inhibition and Other Immunosuppressants in the Development of Uveal and Cutaneous Melanoma.
Damento GM; Pulido JS; Abbott BA; Hodge DO; Dalvin LA
Mayo Clin Proc; 2019 Jul; 94(7):1287-1295. PubMed ID: 31272570
[TBL] [Abstract][Full Text] [Related]
9. Increasing Incidence of Melanoma in the Elderly: An Epidemiological Study in Olmsted County, Minnesota.
Olazagasti Lourido JM; Ma JE; Lohse CM; Brewer JD
Mayo Clin Proc; 2016 Nov; 91(11):1555-1562. PubMed ID: 27692970
[TBL] [Abstract][Full Text] [Related]
10. Comorbid cancer in Parkinson's disease.
Lo RY; Tanner CM; Van Den Eeden SK; Albers KB; Leimpeter AD; Nelson LM
Mov Disord; 2010 Sep; 25(12):1809-17. PubMed ID: 20669266
[TBL] [Abstract][Full Text] [Related]
11. Survival study of Parkinson disease in Olmsted County, Minnesota.
Elbaz A; Bower JH; Peterson BJ; Maraganore DM; McDonnell SK; Ahlskog JE; Schaid DJ; Rocca WA
Arch Neurol; 2003 Jan; 60(1):91-6. PubMed ID: 12533094
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the relationship between Parkinson disease and melanoma.
Liu R; Gao X; Lu Y; Chen H
Neurology; 2011 Jun; 76(23):2002-9. PubMed ID: 21646627
[TBL] [Abstract][Full Text] [Related]
13. Family history of melanoma and Parkinson disease risk.
Gao X; Simon KC; Han J; Schwarzschild MA; Ascherio A
Neurology; 2009 Oct; 73(16):1286-91. PubMed ID: 19841380
[TBL] [Abstract][Full Text] [Related]
14. Increased Odds of Melanoma: Parkinson's Disease, Essential Tremor, Dystonia versus Controls.
Shalaby SY; Louis ED
Neuroepidemiology; 2016; 46(2):128-36. PubMed ID: 26820576
[TBL] [Abstract][Full Text] [Related]
15. Association of Premenopausal Bilateral Oophorectomy With Parkinsonism and Parkinson Disease.
Rocca WA; Smith CY; Gazzuola Rocca L; Savica R; Mielke MM
JAMA Netw Open; 2022 Oct; 5(10):e2238663. PubMed ID: 36287560
[TBL] [Abstract][Full Text] [Related]
16. Medical records documentation of constipation preceding Parkinson disease: A case-control study.
Savica R; Carlin JM; Grossardt BR; Bower JH; Ahlskog JE; Maraganore DM; Bharucha AE; Rocca WA
Neurology; 2009 Nov; 73(21):1752-8. PubMed ID: 19933976
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of malignant melanoma in Israeli patients with Parkinson's disease.
Inzelberg R; Rabey JM; Melamed E; Djaldetti R; Reches A; Badarny S; Hassin-Baer S; Cohen O; Trau H; Aharon-Peretz J; Milo R; Schwartz M; Huberman M; Gilead L; Barchana M; Liphshiz I; Fitzer-Attas C; Giladi N
J Neural Transm (Vienna); 2011 Aug; 118(8):1199-207. PubMed ID: 21298300
[TBL] [Abstract][Full Text] [Related]
18. Overlapping genetic architecture between Parkinson disease and melanoma.
Dube U; Ibanez L; Budde JP; Benitez BA; Davis AA; Harari O; Iles MM; Law MH; Brown KM; ; ; Cruchaga C
Acta Neuropathol; 2020 Feb; 139(2):347-364. PubMed ID: 31845298
[TBL] [Abstract][Full Text] [Related]
19. Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration.
Dalvin LA; Starr MR; AbouChehade JE; Damento GM; Garcia M; Shah SM; Hodge DO; Meissner I; Bakri SJ; Iezzi R
JAMA Ophthalmol; 2019 May; 137(5):483-490. PubMed ID: 30703203
[TBL] [Abstract][Full Text] [Related]
20. Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementia.
Melton LJ; Leibson CL; Achenbach SJ; Bower JH; Maraganore DM; Oberg AL; Rocca WA
Mov Disord; 2006 Sep; 21(9):1361-7. PubMed ID: 16703587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
